Publication: 3896

Publication: 3896

Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum ineligible/refractory metastatic urothelial cancer

URL

Google Scholar

Citation:: J Clin Oncol vol 41 (6) TPS589 Journal of Clinical Onc

Meeting Instance:: ASCO GU 2023
Year:: 2023
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: Himanshu Nagar Karla Ballman Scott T. Tagawa Alan Tan Bishoy M. Faltas Arshin Sheybani Shiva Baghaie Lawrence H. Schwartz David Kozono Jeffrey Bogart Olivia Conway Gina Mazza Ronald Chen Andrew Lacetti Jonathan Rosenberg Michael J. Morris

Networks:: IWORC, KANSAS, LAPS-MA036, LAPS-NY016, LAPS-TN008, NY018, NY141

Study: Alliance-A032002
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: